AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg
Source: SeekingAlpha
2026-03-07 13:16:21 ET
More on AtaiBeckley
- AtaiBeckley Inc. (ATAI) Analyst/Investor Day Transcript
- AtaiBeckley Inc. (ATAI) Discusses Positive Topline Results From Exploratory Phase IIa Study of EMP-01 in Social Anxiety Disorder - Slideshow
- AtaiBeckley Inc. (ATAI) Discusses Positive Topline Results From Exploratory Phase IIa Study of EMP-01 in Social Anxiety Disorder Transcript
- Psychedelics stocks could benefit from marijuana rescheduling: Jefferies
- Seeking Alpha’s Quant Rating on AtaiBeckley
Read the full article on Seeking Alpha
For further details see:
AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg
Jefferies Financial Group Inc.
NASDAQ: JEF
JEF Trading
3.31% G/L:
$38.96 Last:
1,858,407 Volume:
$38.39 Open:
JEF Latest News
March 09, 2026 06:45:00 am
Jefferies Discloses Facts About Western Alliance and Western Alliance's Loan Solely Against First Brands Receivables
March 07, 2026 08:03:11 am
JEF ALERT: Kaplan Fox is Investigating Jefferies Financial Group Inc. (JEF) for Potential Securities Law Violations
JEF Stock Data
$12,376,673,547
165,766,403
7.96%
264
N/A
Capital Markets
Finance
US
New York
